• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

多发性骨髓瘤患者中SOCS-1基因的表观遗传学和遗传学研究

Epigenetic and genetic investigation of SOCS-1 gene in patients with multiple myeloma.

作者信息

Tuncel Fatıma Ceren, Serin Istemi, Pehlivan Sacide, Oyaci Yasemin, Pehlivan Mustafa

机构信息

Department of Medical Biology, Faculty of Medicine, Institute of Health Sciences, Istanbul University, Istanbul, Turkey.

Department of Hematology, Istanbul Training and Research Hospital, University of Health Sciences, Istanbul, Turkey.

出版信息

Blood Res. 2022 Dec 31;57(4):250-255. doi: 10.5045/br.2022.2022097. Epub 2022 Oct 27.

DOI:10.5045/br.2022.2022097
PMID:36289192
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9812727/
Abstract

BACKGROUND

The suppressor of cytokine signaling-1 (SOCS-1) functions to induce an appropriate immune response and is an essential physiological regulator of interferon signaling. DNA methylation involves adding a methyl group to the carbon 5 position of cytosine. Besides comparing SOCS-1 gene methylation status between patients with multiple myeloma (MM) and healthy controls, this study also aimed to demonstrate the effect of SOCS-1 gene distribution and the effect of methylation of SOCS-1 on progression-free survival (PFS) and overall survival (OS).

METHODS

This study included 120 patients diagnosed with MM between January 2018 and 2020 and 80 healthy individuals. The distribution of the SOCS-1 genotypes was statistically compared between MM patients and healthy controls. Additionally, the statistically significant effects of these genotypes on survival were examined.

RESULTS

The CA/CA genotype of SOCS-1 was significantly higher in healthy controls (=0.001), while the Del/Del genotype was significantly higher in patients with MM (=0.034). The percent methylated reference (PMR) value of the SOCS-1 gene was significantly higher in the healthy controls (median, 43.48; range, 2.76‒247.75; =0.001). Patients with a PMR value of ≥43.48 were 3.125 times more likely to develop progression than those with a PMR value of <43.48.

CONCLUSION

The effects of SOCS-1 polymorphisms on the pathogenesis of.

摘要

背景

细胞因子信号转导抑制因子1(SOCS-1)在诱导适当的免疫反应中发挥作用,是干扰素信号传导的重要生理调节因子。DNA甲基化是指在胞嘧啶的5号碳位添加一个甲基基团。除了比较多发性骨髓瘤(MM)患者和健康对照者之间的SOCS-1基因甲基化状态外,本研究还旨在证明SOCS-1基因分布的影响以及SOCS-1甲基化对无进展生存期(PFS)和总生存期(OS)的影响。

方法

本研究纳入了2018年1月至2020年期间确诊为MM的120例患者和80名健康个体。对MM患者和健康对照者之间的SOCS-1基因型分布进行统计学比较。此外,还检查了这些基因型对生存的统计学显著影响。

结果

健康对照者中SOCS-1的CA/CA基因型显著更高(=0.001),而MM患者中Del/Del基因型显著更高(=0.034)。健康对照者中SOCS-1基因的甲基化参考百分比(PMR)值显著更高(中位数为43.48;范围为2.76‒247.75;=0.001)。PMR值≥43.48的患者发生疾病进展的可能性是PMR值<43.48患者的3.125倍。

结论

SOCS-1多态性对……发病机制的影响。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1cb2/9812727/f4797f34bde4/br-57-4-250-f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1cb2/9812727/f4797f34bde4/br-57-4-250-f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1cb2/9812727/f4797f34bde4/br-57-4-250-f1.jpg

相似文献

1
Epigenetic and genetic investigation of SOCS-1 gene in patients with multiple myeloma.多发性骨髓瘤患者中SOCS-1基因的表观遗传学和遗传学研究
Blood Res. 2022 Dec 31;57(4):250-255. doi: 10.5045/br.2022.2022097. Epub 2022 Oct 27.
2
Prognostic relevance of aberrant SOCS-1 gene promoter methylation in myelodysplastic syndromes patients.骨髓增生异常综合征患者中异常的SOCS-1基因启动子甲基化的预后相关性
Int J Lab Hematol. 2015 Apr;37(2):265-71. doi: 10.1111/ijlh.12283. Epub 2014 Aug 13.
3
SOCS-1, a negative regulator of cytokine signaling, is frequently silenced by methylation in multiple myeloma.细胞因子信号转导负调控因子SOCS-1在多发性骨髓瘤中常因甲基化而沉默。
Blood. 2003 Apr 1;101(7):2784-8. doi: 10.1182/blood-2002-06-1735. Epub 2002 Nov 27.
4
Global methylation and promoter-specific methylation of the , , , and genes and their expression in patients with multiple myeloma during active disease and remission.多发性骨髓瘤患者在疾病活动期和缓解期时,、、、和基因的整体甲基化、启动子特异性甲基化及其表达情况。
Exp Ther Med. 2017 May;13(5):2442-2450. doi: 10.3892/etm.2017.4274. Epub 2017 Mar 28.
5
SOCS-1 promoter methylation and treatment response in chronic hepatitis C patients receiving pegylated-interferon/ribavirin.SOCS-1 启动子甲基化与聚乙二醇干扰素/利巴韦林治疗慢性丙型肝炎患者的应答反应。
J Clin Immunol. 2013 Aug;33(6):1110-6. doi: 10.1007/s10875-013-9903-4. Epub 2013 May 24.
6
SOCS-1 1478 CA/del gene polymorphism affects survival in colorectal carcinoma.SOCS-1 1478 CA/del 基因多态性影响结直肠癌患者的生存。
Niger J Clin Pract. 2022 Mar;25(3):239-247. doi: 10.4103/njcp.njcp_1309_21.
7
miR-29b induces SOCS-1 expression by promoter demethylation and negatively regulates migration of multiple myeloma and endothelial cells.微小RNA-29b通过启动子去甲基化诱导细胞因子信号转导抑制因子-1表达,并对多发性骨髓瘤细胞和内皮细胞的迁移发挥负向调节作用。
Cell Cycle. 2013 Dec 1;12(23):3650-62. doi: 10.4161/cc.26585. Epub 2013 Sep 25.
8
[Arsenic trioxide induces socs-1 gene demethylation in myeloma cell lines].三氧化二砷诱导骨髓瘤细胞系中socs - 1基因去甲基化
Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2008 Oct;16(5):1064-8.
9
The SOCS-1 -1478CA/del polymorphism is not associated with colorectal cancer or age at onset in Turkish subjects.细胞因子信号转导抑制因子-1(SOCS-1)基因-1478CA/del多态性与土耳其人群的结直肠癌及发病年龄无关。
Asian Pac J Cancer Prev. 2013;14(12):7583-6. doi: 10.7314/apjcp.2013.14.12.7583.
10
Role of cytokines in multiple myeloma: IL-1RN and IL-4 VNTR polymorphisms.细胞因子在多发性骨髓瘤中的作用:白细胞介素-1受体拮抗剂(IL-1RN)和白细胞介素-4可变数目串联重复序列(IL-4 VNTR)多态性
Cytokine. 2022 May;153:155851. doi: 10.1016/j.cyto.2022.155851. Epub 2022 Mar 9.

引用本文的文献

1
Mesenchymal stromal cells in bone marrow niche of patients with multiple myeloma: a double-edged sword.多发性骨髓瘤患者骨髓微环境中的间充质基质细胞:一把双刃剑。
Cancer Cell Int. 2025 Mar 26;25(1):117. doi: 10.1186/s12935-025-03741-x.
2
Discrimination of Lung Cancer and Benign Lung Diseases Using BALF Exosome DNA Methylation Profile.利用支气管肺泡灌洗术(BALF)外泌体DNA甲基化谱鉴别肺癌与良性肺部疾病
Cancers (Basel). 2024 Aug 5;16(15):2765. doi: 10.3390/cancers16152765.

本文引用的文献

1
What are the roles of global DNA and APC 2 gene promotor hypermethylation in multiple myeloma?全球 DNA 和 APC2 基因启动子高甲基化在多发性骨髓瘤中的作用是什么?
Mol Biol Rep. 2021 Dec;48(12):7875-7882. doi: 10.1007/s11033-021-06813-z. Epub 2021 Oct 12.
2
Decoding DNA methylation in epigenetics of multiple myeloma.解读多发性骨髓瘤表观遗传学中的DNA甲基化
Blood Rev. 2022 Jan;51:100872. doi: 10.1016/j.blre.2021.100872. Epub 2021 Jul 31.
3
Oral azacitidine (CC-486) in combination with lenalidomide and dexamethasone in advanced, lenalidomide-refractory multiple myeloma (ROAR study).
口服阿扎胞苷(CC-486)联合来那度胺和地塞米松治疗晚期、来那度胺难治性多发性骨髓瘤(ROAR 研究)。
Leuk Lymphoma. 2019 Sep;60(9):2143-2151. doi: 10.1080/10428194.2019.1571201. Epub 2019 Jun 11.
4
Drug resistance in multiple myeloma.多发性骨髓瘤的耐药性。
Cancer Treat Rev. 2018 Nov;70:199-208. doi: 10.1016/j.ctrv.2018.09.001. Epub 2018 Sep 4.
5
Hypermethylation of promoter with NSCLC is specific for females, non-smokers and people younger than 65.非小细胞肺癌(NSCLC)启动子的高甲基化在女性、不吸烟者和65岁以下人群中具有特异性。
Oncol Lett. 2018 Jun;15(6):9017-9024. doi: 10.3892/ol.2018.8535. Epub 2018 Apr 18.
6
CCL2 promoter hypomethylation is associated with gout risk in Chinese Han male population.CCL2 启动子低甲基化与中国汉族男性痛风风险相关。
Immunol Lett. 2017 Oct;190:15-19. doi: 10.1016/j.imlet.2017.06.011. Epub 2017 Jul 6.
7
Cytokine signal suppressor (SOCS) 1-1478 CA/del gene polymorphism in Turkish patients with polycystic ovary syndrome.土耳其多囊卵巢综合征患者中细胞因子信号抑制因子(SOCS)1-1478 CA/del基因多态性
J Obstet Gynaecol. 2017 Oct;37(7):896-901. doi: 10.1080/01443615.2017.1309011. Epub 2017 Jun 1.
8
Revised International Staging System for Multiple Myeloma: A Report From International Myeloma Working Group.多发性骨髓瘤修订国际分期系统:国际骨髓瘤工作组报告
J Clin Oncol. 2015 Sep 10;33(26):2863-9. doi: 10.1200/JCO.2015.61.2267. Epub 2015 Aug 3.
9
Association of SOCS1 (- 820) (rs33977706) gene polymorphism with chronic periodontitis: A case-control study in Brazilians.细胞因子信号转导抑制因子1(SOCS1)(-820)(rs33977706)基因多态性与慢性牙周炎的关联:巴西人的病例对照研究
Meta Gene. 2015 Jul 9;5:124-8. doi: 10.1016/j.mgene.2015.06.005. eCollection 2015 Sep.
10
DNA methylation alterations in multiple myeloma as a model for epigenetic changes in cancer.多发性骨髓瘤中的 DNA 甲基化改变作为癌症表观遗传改变的模型。
Wiley Interdiscip Rev Syst Biol Med. 2010 Nov-Dec;2(6):654-69. doi: 10.1002/wsbm.89.